Loss of p27 Expression Is Associated with Poor Prognosis in Stage I–II Pancreatic Cancer

Anne Juuti,Stig Nordling,Johanna Louhimo,Johan Lundin,K. Von Boguslawski,Caj Haglund

Loss of p27 Expression Is Associated with Poor Prognosis in Stage I–II Pancreatic Cancer

2003

Anne Juuti
Stig Nordling
Johanna Louhimo
Johan Lundin
K. Von Boguslawski
Caj Haglund

Objective: p27 is a cyclin-dependent kinase inhibitor that prevents progression of the cell cycle from G1 phase. Postranscriptional loss of p27 correlates with poor prognosis in var

Keywords:

Pancreatic disease
Pathology
Neoplasm
Cancer
Cell cycle
Pancreatic cancer
Kinase
Biology
Pancreas
Medicine
Anatomical pathology
Survival analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations